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Renal biopsyTubulointerstitial fibrosis (TIF) plays a central role in the progression to end-stage renal disease. Tubular
epithelial cells (TECs) undergo epithelial–mesenchymal transition (EMT) and may contribute to the pro-
gression of TIF. Using immunohistochemistry, the primary aim of this study was to assess the expression
of b-catenin, human leukocyte antigen-DR (HLA-DR) and vimentin in renal biopsies from dogs with spon-
taneous kidney diseases of varying severities. Morphological diagnosis, severity of inflammation, TIF,
HLA-DR expression and clinicopathological variables were compared in dogs with renal injury to identify
any potential relationship between the different factors; b-catenin down-regulation was used as a marker
of EMT.
Fibrosis, HLA-DR expression, serum creatinine concentration (SCr), and urine protein-to-creatinine
ratio (UPC) were all increased and b-catenin expression decreased in dogs with primary glomerular dis-
ease compared with dogs with acute tubular necrosis. HLA-DR expression by TECs was positively corre-
lated to fibrosis, inflammation, UPC, and SCr. b-catenin expression was negatively correlated to fibrosis,
inflammation and HLA-DR expression. The progression of renal failure correlated closely with tubuloin-
terstitial damage. De novo HLA-DR expression associated with b-catenin down-regulation by TECs may
represent a possible step in the progression of TIF and EMT.
 2013 Elsevier Ltd. All rights reserved.Introduction
Kidney lesions can primarily involve the glomeruli, tubulointer-
stitium, or renal vessels. However, regardless of the initiating site
of injury, all compartments often eventually become affected (Fin-
co et al., 1999). Serum creatinine concentration (SCr), urinalysis
findings, and renal biopsy are diagnostic tools commonly used to
evaluate renal damage, guide treatment decisions, and determine
prognosis (Lees, 2004).
Tubulointerstitial damage (TID), independent of the initial
cause of the injury, plays a central role in the progression of renal
disease, leading to an irreversible decline in renal function and ulti-
mately resulting in end-stage renal disease (ESRD) (MacDougall
et al., 1986). TID is characterized by loss of renal tubules, increased
number of interstitial myofibroblasts, and interstitial accumulation
of extracellular matrix (ECM) usually with inflammatory cell
infiltrates (Zeisberg and Duffield, 2010). Various studies havedemonstrated a potential role of epithelial-to-mesenchymal tran-
sition (EMT) in the development of renal interstitial fibrosis both
in humans and dogs (Rastaldi et al., 2002; Aresu et al., 2007).
EMT is observed in three distinct biological settings with very dif-
ferent functional consequences. In type 1 EMT, cells lose their epi-
thelial phenotype, acquire mesenchymal features, and migrate to
generate new organs in the embryo. This mechanism is replicated
in Type 3 EMT, where cancerous cells acquire the ability to dissem-
inate by metastasis. In type 2 EMT, epithelial cells subject to injury
represent a source of new fibroblasts in the interstitium.
Type 2 EMT in the kidney is described as an organ repair-asso-
ciated event (Kalluri and Weinberg, 2009). One of the first events
leading to EMT is down-regulation of adhesion molecules (E-cad-
herin and b-catenin) that normally mediate cell–cell and cell-base-
ment membrane interactions and attachment of epithelial cells
(Tian et al., 2011). This is followed by detachment of cells, acquisi-
tion of cell mobility, and expression of de novo mesenchymal
markers (Rastaldi et al., 2002; Kalluri and Neilson, 2003). Direct
evidence for the active role of b-catenin as an integral component
of intercellular junctions has been demonstrated, and the loss of itssion in
oi.org/
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(Aresu et al., 2008b; Tian et al., 2011).
Class II major histocompatibility complex (MHC) molecules are
heterodimeric transmembrane proteins that are responsible for
activation of antigen-specific T helper lymphocytes during antigen
processing by various antigen-presenting cells (APCs) (Frei et al.,
2010). MHC is also known as human leukocyte antigen (HLA). Hu-
man class II genes are encoded by genes in the HLA-D region,
which includes three subregions called DQ, DP, and DR. The HLA-
DR subregions are highly conserved in nearly all mammals, includ-
ing the dog (Yuhki et al., 2007). In humans, tubular epithelial cells
(TECs) are able to express class II MHC under certain conditions,
such as in renal allografts during graft-versus-host reactions
(Cheng et al., 1989). Class II MHC expression in TECs has also been
described in a mouse model of systemic lupus erythematosus and
in canine chronic interstitial nephritis (Wuthrich et al., 1989;
Vilafranca et al., 1995).
The aim of the present study was to assess the relationship be-
tween b-catenin and HLA-DR expression by TECs as assessed by
immunohistochemistry (IHC) and the severity of chronic tubuloin-
terstitial damage (CTID) in dogs with naturally-occurring renal dis-
ease due to various causes.Materials and methods
Case selection and clinical chemistry
Canine renal biopsies (n = 28) were selected from routine diagnostic cases sub-
mitted to the Histopathology Service, Department of Comparative Biomedicine and
Food Science, University of Padova between January 2009 and December 2011. All
biopsies had a minimum of 12 evaluable glomeruli in 10 serial histological sections
(3 lm in thickness) and were composed of only cortex, as the medulla is usually
avoided during biopsy procedures to reduce the risk of haemorrhage. Five renal
biopsies from dogs with no signs or history of renal disease were used as controls.
SCr and urine protein–creatinine ratio (UPC) were provided by the referring clini-
cians at the time of renal biopsy submission. Proteinuria was defined as UPC > 0.5
and azotaemia by SCr > 123.8 lmol/L.
Classification of renal biopsies
Renal biopsies were evaluated by light microscopy, immunofluorescence, and
electron microscopy as previously described (Aresu et al., 2008a; Aresu et al.,
2012). Based on biopsy findings, each case was assigned to one of five diagnostic
categories as follows: (1) acute tubular necrosis (ATN), (2) amyloidosis (AMYL),
(3) chronic glomerulosclerosis (CGS), (4) membranoproliferative glomerulonephri-
tis (MPGN), and (5) mesangioproliferative glomerulonephritis (MeGN).
ATN was characterized by primary damage to proximal tubules, which showed
degeneration and necrosis of epithelial cells. Multifocally, the injured tubules con-
tained sloughed tubular epithelial cytoplasm, pyknotic nuclear debris and mineral-
ization. AMYL was characterized by glomeruli with diffuse and global mesangial
expansion by an amorphous congophilic material consistent with amyloid. CGS
was characterized by glomeruli with moderate to severe global mesangial matrix
increase, with or without hypercellularity, and absence of immune deposits. MPGN
was characterized by glomeruli that exhibited increased mesangial matrix and cel-
lularity, thickening of glomerular capillary walls with endothelial hypertrophy, and
immune deposits in the capillary wall and mesangium. MeGN was characterized by
glomeruli with mesangial hypercellularity and increased mesangial matrix with no
involvement of the capillary lumen, together with immune deposits in the mesan-
gium as demonstrated on ultrastructural examination.
Histological indices of interstitial inflammation and fibrosis
Interstitial inflammation was evaluated using haematoxylin and eosin (HE)-
stained sections. The inflammation index was determined by counting the number
of inflammatory cell nuclei (lymphocytes, plasma cells and neutrophils) in 10 ran-
domly selected microscopic fields of renal cortex with a 20 objective. The index
for each case was expressed as the average number of inflammatory cells per field.
Interstitial fibrosis was evaluated using Masson’s Trichrome-stained sections. Inter-
stitial fibrosis was evaluated in the cortex and severity of cortical interstitial fibrosis
(CIF) was graded by examining 20 randomly selected fields with a 20 objective. A
semi-quantitative assessment of the extent of fibrosis for each field was done as fol-
lows: grade 0: normal tubulointerstitium; grade 1: <25%; grade 2: 26–50%; grade 3:
>51% (Aresu et al., 2007). The final score for each biopsy was the total of the scores
for each field ranging from 0 to 60 (Nabity et al., 2012).Please cite this article in press as: Benali, S.L., et al. De novo expression of hum
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For IHC, serial paraffin sections (3 lm) were placed on surface-coated slides
(Superfrost Plus). Slides were incubated at 37 C for 30 min before the immuno-
staining procedures. Staining was performed using an automatic immunostainer
(Ventana Benchmark XT, Roche-Diagnostics), which uses a kit with a secondary
antibody with a horseradish peroxidase (HRP)-conjugated polymer that binds
mouse and rabbit primary antibodies (ultraViews Universal DAB, Ventana Medical
System). All reagents were dispensed automatically except for the primary anti-
body, which was dispensed by hand.
A mouse monoclonal antibody against the a-chain of human HLA-DR (Clone
TAL.1B5, Dako, dilution 1:50) was used. The antibody was tested in canine lymph
nodes, tonsils and thymus to determine cross-species reactivity. A single band of
34 kDa was identified by immunoblots using canine peripheral lymphocytes.
Cross-reactivity with canine tissue was also confirmed by previous studies (Darbès
et al., 1997; German et al., 1998). A mouse monoclonal antibody against human b-
catenin (clone 14, Transduction Laboratories, dilution 1:100) was used to detect b-
catenin expression and cross-reactivity of this antibody has previously been tested
(Aresu et al., 2008b). Tissues were incubated with the primary antibody for 32 min
at room temperature (RT) for HLA-DR and for 24 min at 42 C for b-catenin. Slides
were counterstained with Mayer’s haematoxylin. Interstitial dendritic cells and epi-
thelial cells in normal renal tissue were used as positive controls for HLA-DR and b-
catenin, respectively. Negative controls were performed by replacing the primary
antibody with antibody diluent.
Quantification of HLA-DR and b-catenin expression was assessed by counting
the number of positively labelled and non-stained TECs in 10 randomly selected
fields with a 40 objective. Expression of HLA-DR and b-catenin was determined
by calculating the percentage of positively labelled cells among the total as follows:
positively labelled cells
ðpositively labelled cellsþ non-stained TECsÞ  100
Double immunolabeling for HLA-DR and vimentin (V9 clone, monoclonal
mouse, Dako) was performed on selected representative cases using an automatic
immunostainer (Ventana Benchmark XT) according to the manufacturer’s instruc-
tions. Tissues were incubated with HLA-DR as described above, followed by incuba-
tion with vimentin (diluted 1:150 and incubated 20 min at RT). Peroxidase activity
was demonstrated using ultraViews universal diaminobenzidine (DAB, Ventana
Medical System, brown to black chromogen reaction) for vimentin. For HLA-DR
detection, ultraView universal alkaline phosphatase red detection kit was used
(red chromogen reaction). Slides were counterstained with periodic acid Schiff
(PAS) to highlight tubular basement membranes.
Statistical analysis
One-way analysis of variance (ANOVA) using the GLM procedure of the SAS
Institute was carried out to assess relationships between renal disease diagnostic
categories, magnitudes of azotaemia and proteinuria, and histologic indices of
interstitial inflammation and fibrosis. Effects of different disease categories (ATN,
AMYL, CGS, MPGN, MeGN, and NORMAL) on CIF grade, inflammation index, SCr,
and UPC were examined. The degrees of freedom of the different disease categories
were decomposed by a multiple comparisons test using the Bonferroni adjustment
method (SAS Institute) to analyse the relative significance of each disease category
within each analysed variable. Correlation and linear regression analyses were car-
ried out with the CORR and REG procedures of SAS, respectively (SAS Institute),
comparing HLA-DR with CIF grade, inflammation index, SCr, UPC, and b-catenin
expression. Correlation and linear regression analysis were also carried out for
CIF grade, inflammation score, SCr, and UPC in relation to b-catenin expression
(i.e., using b-catenin expression as a dependent variable). Lastly, correlation and lin-
ear regression analysis were also conducted for inflammation score, SCr, and UPC in
relation to CIF grade (i.e., using CIF grade as a dependent variable).
Results
Dogs, diagnostic categories, and clinical chemistry findings
A total of 33 canine renal biopsies were examined (28 affected
dogs, 5 controls). The 28 dogs with renal disease were composed of
12 females, 15 males, and 1 unspecified. These dogs ranged in age
from 1 to 13 years with a median of 6, and Boxer was the most rep-
resented breed (6/28 dogs). Primary glomerular lesions were diag-
nosed in 21 biopsies: 9 CGS, 7 MPGN, 3 MeGN and 2 AMYL. In
seven dogs the histological diagnosis was primary ATN. The con-
trols dogs were 4 month-old Beagles, 3 males and 2 females.
All but one of the affected dogs were azotemic
(SCr > 123.8 lmol/L) and all but two were proteinuric (UPC > 0.5).
Clinical data are shown in Table 1.an leukocyte antigen-DR (HLA-DR) and loss of beta-catenin expression in
in canine renal diseases. The Veterinary Journal (2013), http://dx.doi.org/
Table 1
Comparison of clinical and histopathological variables according to diagnostic categories.
Diagnostic categoriesa Normal ATN AMYL MPGN MeGN CGS
Number of dogs 5 7 2 7 3 9
sCrb
Mean 70.7 141.4 1034.3 689.5 848.6 512.7
Median 79.6 132.6 1034.3 769.1 1007.8 618.8
Range 61.9–97.2 97.2–185.6 1007.8–1069 300.6–919.4 468.5–742.6 132.6–742.6
UPCc
Mean 0.24 1.45 3.6 3.6 4.8 2.5
Median 0.2 0.7 3.6 3.0 5.9 2.2
Range 0.2–0.3 0.3–1.2 3.1–4.1 1.8–6.5 1.9–6.7 1.0–4.1
Inflammation indexd
Mean 0 5.41 77.1 39.4 54.1 34.3
Median 0 5.1 77.1 35.5 65.4 33.1
Range 0 3.5–8.9 75.3–78.8 20.5–80.9 22.3–74.7 3.2–75.7
CIF scoree
Mean 5.6 11.6 50.5 32.3 40.0 31.2
Median 5.0 11.0 50.5 30.0 46.0 34.0
Range 12–53 8–55 8–15 22–52 51–52 5–7
a ATN, acute tubular necrosis; AMYL, amyloidosis; MPGN, membranoproliferative glomerulonephritis; MeGN, mesangioproliferative glomerulonephritis; CGS, chronic
glomerulosclerosis.
b sCr: serum creatinine (lmol/L).
c UPC: urine protein–creatinine ratio.
d Inflammation index: average number of inflammatory cells per field in 10 fields (200).
e CIF, chronic interstitial fibrosis.
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Inflammation was present in all dogs with renal disease. In dogs
with acute tubular damage, the infiltrate was mild and multifocal,
mainly composed of lymphocytes and rare neutrophils. In dogs
with glomerular disease, the inflammation index was greater and
mainly composed of lymphocytes and plasma cells (Table 1). In
dogs with ATN, the amount of fibrosis was significantly lower com-
pared with the other disease categories (P < 0.01). Independently of
the histological diagnosis, the CIF grade was associated with the
inflammation index (r = 0.986), UPC (r = 0.914), and sCr
(r = 0.904) (P < 0.05).Fig. 2. Dog, renal biopsy, membranoproliferative glomerulonephritis. HLA-DR
expression is detectable multifocally in the cytoplasm of proximal tubular epithelial
cells. Immunohistochemical staining for HLA-DR, haematoxylin counterstain. (Bar,
100 lm).Expression of HLA-DR and b-catenin in tubular epithelial cells
In control dogs, the expression of HLA-DR was restricted to the
cytoplasm of dendritic cells within the renal interstitium. In all
control dogs and one dog with minimal tubulointerstitial involve-
ment, TECs were negative for HLA-DR staining (Fig. 1). HLA-DR
labelling was present in TECs in all other dogs (Fig. 2). The intensityFig. 1. Dog, renal biopsy, control. Diffuse cytoplasmatic HLA-DR expression is
evident in interstitial dendritic cells. Immunohistochemical staining for HLA-DR,
haematoxylin counterstain. (Bar, 50 lm).
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the cytoplasm. Scattered lymphocytes and macrophages were also
positive for HLA-DR. The number of HLA-DR positive TECs was sig-
nificantly increased in biopsies with higher severity of CIF andTable 2
Comparison of immunohistochemical results according to diagnostic categories.
Diagnostic Categorya Normal ATN AMYL MPGN MeGN CGS
Number of dogs 5 7 2 7 3 9
HLA-DR expression in TECs (% positively labelled cells)b
Mean 0 4 64 41 5 33
Median 0 5 64 34 6 39
Min–Max 0 0–8 64–64 4–84 28–64 0–62
b-Catenin expression in TECs (% positively labelled cells)b
Mean 97 90 30 59 48 62
Median 97 90 30 62 39 61
Min–Max 96–99 87–92 29–31 21–74 35–68 28–92
a ATN, acute tubular necrosis; AMYL, amyloidosis; MPGN, membranoproliferative
glomerulonephritis; MeGN, mesangioproliferative glomerulonephritis; CGS,
chronic glomerulosclerosis;
b TECs: tubular epithelial cells.
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Fig. 4. Correlation between chronic interstitial fibrosis (CIF) grade and percentage
of beta-catenin positive immunolabelled tubular epithelial cells (%).
Fig. 5. Correlation between inflammation index and percentage of HLA-DR positive
immunolabelled tubular epithelial cells (%).
Fig. 6. Correlation between UPC and percentage of HLA-DR positive immunola-
belled tubular epithelial cells (%).
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(Tables 1 and 2). Multifocally, TECs showed more intense immuno-
reactivity for HLA-DR when adjacent to inflammatory cells (Fig. 3).
Uniform membranous and cytoplasmatic b-catenin staining
was observed in TECs in control dogs. A reduction of b-catenin
expression was observed in the different renal diseases (Table 2).
The number of b-catenin positive TECs was negatively correlated
with the severity of inflammation (r = 0.981), CIF grade
(r = 0.984), and with UPC (r = 0.906) and SCr (r = 0.901). More-
over, HLA-DR and b-catenin expression by TECs were negatively
correlated (Figs. 4–7).
Evaluation of double immunostaining for HLA-DR and vimentin
showed four different patterns: (1) tubules with a mixture of cells
positive for either HLA-DR or vimentin, (2) tubules with only
vimentin-positive cells, (3) tubules with only HLA-DR positive
cells, and (4) tubules with co-localization of both markers in the
same cell (Fig. 8). In control biopsies, TECs were not immunola-
belled by either marker.
Discussion
The present study investigated the immunohistochemical
expression of HLA-DR and b-catenin in renal biopsies from dogs
with various kidney diseases. Association of expression of these
markers with clinico-pathological data, as well as with measures
of interstitial inflammation and fibrosis was examined. The inflam-
mation index and CIF grade were significantly increased in dogs
with primary glomerular diseases compared to dogs with primary
acute tubular injury. No differences were evident for CIF grade and
inflammation index among the CGS, MPGN, and MeGN disease
categories.
Acute tubular damage is frequently characterized by degenera-
tion and necrosis of tubules with no involvement of the interstit-
ium, while glomerular diseases are associated with a variable
increase in extracellular matrix, fibroblasts, and inflammatory cells
in the interstitium at the time of biopsy. One possible explanation
for the lack of tubulointerstitial changes in the ATN cases may be
the rapid clinical onset of the disease in these dogs, since all ATN
dogs were biopsied within a few days of the initial injury. With pri-
mary glomerular diseases, compensatory mechanisms such as glo-
merular hypertrophy and hyperfiltration are described to maintain
kidney function for some time during the development of the pri-
mary process; therefore, secondary tubulointerstitial lesions may
already be chronic and advanced by the time clinical signs become
evident (Finco et al., 1999).Fig. 3. Dog, renal biopsy, membranoproliferative glomerulonephritis. HLA-DR
expression is diffusely detectable in lymphocytes and tubules adjacent to inflam-
mation. Immunohistochemical staining for HLA-DR, haematoxylin counterstain.
(400; Bar, 50 lm).
Fig. 7. Correlation between percentage of beta-catenin positively immunolabelled
tubular epithelial cells (%) and percentage of HLA-DR positively immunolabelled
tubular epithelial cells (%).
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Fig. 8. Dog, renal biopsy, chronic glomerulosclerosis. Different pattern are present.
(1) HLA-DR and vimentin expression in a single tubule (black arrow-head). (2) HLA-
DR and vimentin co-localization in the cytoplasm of epithelial tubular cells (black
arrow). (3) Diffuse vimentin expression in a tubule (blue arrow). (4) Diffuse HLA-DR
expression in a tubule (blue arrow-head). Double immunostaining for HLA-DR (red
signal) and vimentin (brown signal), periodic acid Schiff (PAS) counterstain (400).
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supporting their insensitivity for detecting early renal disease. This
finding supports the need for additional more sensitive biomarkers
of early damage in canine renal disease as pointed out in recent
studies (Meyer et al., 2010; Smets et al., 2010; Slocum et al.,
2012; Nabity et al., 2012).
The aim of this work was to confirm that decreased b-catenin
expression is correlated with tubulointerstitial damage as has been
previously described in canine EMT (Aresu et al., 2007) and to
examine whether HLA-DR expression by TECs may be part of
EMT. As expected, HLA-DR was expressed by interstitial dendritic
cells, while TECs were negative in the control kidneys. Importantly,
de novo expression of HLA-DR in the cytoplasm of TECs was found
in the diseased kidneys and this expression was correlated with
the CIF grade, UPC, and inflammation index. This result suggests
a possible progressive transition of TECs to APCs. One possible
explanation for this process is that some of the excess proteins
(e.g. albumin) filtered by the glomerulus in primary glomerular
diseases are physiologically reabsorbed by TECs. The proteins ab-
sorbed at the luminal membrane are endocytosed and concen-
trated within vesicles at the apical border of tubular cells. An
overload of filtered protein results in production of chemokines,
cytokines, and growth factors able to promote fibrosis and EMT
(Abbate et al., 1998). Our results show a possible involvement of
TECs in exposing the protein antigens with subsequently presenta-
tion of class II MHC, which may then exacerbate or perpetuate
interstitial inflammation, particularly in glomerular diseases.
Interestingly, more intense HLA-DR immunostaining was found
in TECs adjacent to inflammatory cells, most of which were lym-
phocytes. This may support the possibility that TECs may be able
to directly interact with and activate T helper cells. Different cells
(i.e. macrophages, B lymphocytes, and dendritic cells) are known to
constitutively express HLA-DR (Kelley and Singer, 1993). Other cell
types (i.e. intestinal epithelial cells, endothelial cells, chondrocytes,
and thyroid epithelial cells) have been shown to function in a lim-
ited context as APCs (Wuthrich et al., 1989; German et al., 1998;
Roda, 2010). Their efficiency is considered low and they are re-
ferred to as non-professional APCs. Based on the results of the pres-
ent study, canine TECs could also be considered as non-
professional APCs.
We found that b-catenin showed diffuse membranous and cyto-
plasmic expression in virtually of all TECs in control kidneys, and
progressive loss of staining correlated with worsening of the CIF
grade and higher inflammation index. b-Catenin plays an essentialPlease cite this article in press as: Benali, S.L., et al. De novo expression of hum
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10.1016/j.tvjl.2013.06.006role in maintaining the structural integrity and polarity of epithe-
lial cells, and its decreased expression may reduce adherens junc-
tion formation and lead to epithelial transdifferentiation. In fact, in
the early phase of EMT, the expression of protein constituents of
the tight junctions is decreased in epithelial cells. Subsequently,
epithelial cells lose their intercellular contacts and polarity and un-
dergo cytoskeleton reshaping by expressing proteins specific to
mesenchymal cells, such as vimentin. In contrast to observations
in human kidneys, the EMT of TECs in dogs seems to be character-
ized by de novo expression of vimentin rather than smooth muscle
actin (Aresu et al., 2007).
The negative correlation between expression of HLA-DR and b-
catenin by TECs observed in this study suggests the possibility of a
previously unrecognized phase in the EMT process. To further
investigate this observation, a double IHC protocol for vimentin
and HLA-DR was used. The findings showed several different pat-
terns of expression that may be consistent with the following three
phase hypothesis: (1) when TECs express only HLA-DR, they act as
APCs, presumably preceding the mesenchymal phase of EMT; (2)
when TECs express both markers, a transition from one phase to
another is occurring; (3) when TECs express only vimentin, the
complete EMT process has occurred.Conclusions
This study confirms the progressive decrease in b-catenin
expression in TECs during tubulointerstitial damage associated
with fibrosis and inflammation. De novo expression of HLA-DR in
TECs could contribute to the recruitment of inflammatory cells
and vimentin expression by TECs may be considered as a step dur-
ing EMT. Further investigations on the role of HLA-DR may be help-
ful for determining novel therapeutic strategies to slow or arrest
progression of renal diseases.Conflict of interest statement
None of the authors of this paper has a financial or personal
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